Position in GSK
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$12,580
+$2,222 QoQ
Shares Held
240
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#912
of 1,032 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advantage Trust Co holds $1,835,316 across 10 Drug Manufacturers - General names. GSK ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
865 | $1,037,507 | |
| 2 | ABBV |
AbbVie Inc.
|
939 | $236,289 | |
| 3 | JNJ |
Johnson & Johnson
|
786 | $199,620 | |
| 4 | PFE |
Pfizer Inc
|
5,353 | $128,900 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,700 | $97,954 | |
| 6 | MRK |
Merck & Co., Inc.
|
709 | $91,106 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
138 | $17,434 | |
| 8 | GSK |
GSK plc
This page
|
240 | $12,580 |
All Filings in GSK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,580 | 240 | Shares | Sole | 2026-07-17 | |
| 2025-09-30 | $10,358 | 240 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $9,216 | 240 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||